Brevan Howard Capital Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,071
Closed -$255K 2101
2025
Q2
$255K Sell
4,071
-1,032
-20% -$62K ﹤0.01% 1612
2025
Q1
$307K Buy
5,103
+899
+21% +$55.8K ﹤0.01% 858
2024
Q4
$245K Buy
+4,204
New +$250K ﹤0.01% 845

Other funds holding IHI

Brevan Howard Capital Management's IHI Position: Q3 2025 in Review

Brevan Howard Capital Management sold out of iShares US Medical Devices ETF (IHI) in Q3 2025, closing a stake of 4,071 shares — an estimated $255K sold.

Brevan Howard Capital Management first reported a position in IHI in Q4 2024 and held it in 3 quarters. The position peaked at $307K in Q1 2025. 525 funds tracked by Wall St. Rank hold IHI as of Q3 2025.

  • Brevan Howard Capital Management reported no remaining iShares US Medical Devices ETF position as of Q3 2025 after selling out during the quarter.
  • Brevan Howard Capital Management sold 4,071 iShares US Medical Devices ETF shares in Q3 2025, an estimated $255K.
  • Brevan Howard Capital Management first reported a position in iShares US Medical Devices ETF in Q4 2024 and held it in 3 quarters.
  • Brevan Howard Capital Management's iShares US Medical Devices ETF position peaked at $307K in Q1 2025.
  • 525 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2025.

Based on Brevan Howard Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.